SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001553350-16-001856
Filing Date
2016-04-07
Accepted
2016-04-07 07:10:32
Documents
9
Period of Report
2016-04-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT htbx_8k.htm 8-K 26751
2 AMENDMENT TO EMPLOYMENT AGREEMENT htbxex10z1.htm EX-10.1 8099
3 AMENDMENT TO EMPLOYMENT AGREEMENT htbxex10z2.htm EX-10.2 9210
4 AMENDMENT TO EMPLOYMENT AGREEMENT htbxex10z3.htm EX-10.3 10460
5 EMPLOYMENT AGREEMENT htbxex10z4.htm EX-10.4 56154
6 SEVERANCE AGREEMENT AND GENERAL RELEASE htbxex10z5.htm EX-10.5 84851
7 SEVERANCE AGREEMENT AND GENERAL RELEASE htbxex10z6.htm EX-10.6 84523
8 PRESS RELEASE htbxex99z1.htm EX-99.1 8134
9 GRAPHIC htbxex99z1001.jpg GRAPHIC 133641
  Complete submission text file 0001553350-16-001856.txt   466702
Mailing Address 100 EUROPA DRIVE SUTE 420 CHAPEL HILL NC 27517
Business Address 100 EUROPA DRIVE SUTE 420 CHAPEL HILL NC 27517 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 161558755
SIC: 2834 Pharmaceutical Preparations